The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ROVI FINANCIAL STATEMENTS

Laboratorios Farmaceuticos ROVI — balance sheet, income statement and cash flow trends

ROVILaboratorios Farmaceuticos ROVI

🇪🇸 Spain · MC · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0250 M500 M750 M202020212023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue773.1 M €Gross Profit494.9 M € · 64%Operating Income169.8 M € · 22%Pre-tax Income235.2 M € · 30%Net Income to Owners185.2 M € · 24%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue773.1 M €+3.2%
Gross Profit494.9 M €-22.8%
Operating Income169.8 M €-2.4%
EBITDA266.1 M €+31.0%
Net Income to Owners185.2 M €+40.0%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202020212023202420252026

Capital Structure

Q2 2026
Total Assets1.1 B
  • Equity700.6 M €63%
  • Current Liabilities276.5 M €25%
  • Long-term Liabilities133.4 M €12%

Key Figures

YoY change
Total Assets1.1 B €+29.6%
Total Liabilities410 M €+39.0%
Total Equity700.6 M €+24.3%
Cash & ST Investments128.1 M €+168.9%
Total Debt107.7 M €-16.7%
Net Debt-19.3 M €-123.2%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M202020212023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M252.7 M €Operating-97.3 M €Investing-72.6 M €Financing82.8 M €Net Change

Key Figures

YoY change
Operating Cash Flow252.7 M €+85.0%
Capital Expenditures75.9 M €+17.9%
Free Cash Flow176.8 M €+145.0%
Dividends Paid47.8 M €-15.3%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ROVI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.